Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amrita Krishnan

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphomaRoberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Research Square|October 4, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Frontiers in Immunology|May 3, 2024
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapyVikram Adhikarla, Dennis Awuah, Enrico Caserta, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaAndrzej Jakubowiak, Saad Z Usmani, Amrita Krishnan, et al.
Cancers|October 23, 2021
A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination TherapyVikram Adhikarla, Dennis Awuah, Alexander B Brummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphomaAmrita Krishnan, Auayporn Nademanee, Henry C Fung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myelomaGeorge Somlo, Ricardo Spielberger, Paul Frankel, et al.
Transplantation and Cellular Therapy|January 20, 2024
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Leukemia|July 21, 2018
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myelomaIbrahim Aldoss, Marzia Capelletti, Jihye Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Comparison of reduced-intensity and conventional myeloablative regimens for allogeneic transplantation in non-Hodgkin's lymphomaRoberto Rodriguez, Auayporn Nademanee, Nora Ruel, et al.
Research Square|October 4, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Frontiers in Immunology|May 3, 2024
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapyVikram Adhikarla, Dennis Awuah, Enrico Caserta, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2021
Daratumumab Plus Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaAndrzej Jakubowiak, Saad Z Usmani, Amrita Krishnan, et al.
Cancers|October 23, 2021
A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination TherapyVikram Adhikarla, Dennis Awuah, Alexander B Brummer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphomaAmrita Krishnan, Auayporn Nademanee, Henry C Fung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myelomaGeorge Somlo, Ricardo Spielberger, Paul Frankel, et al.
Transplantation and Cellular Therapy|January 20, 2024
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) TrialEhsan Malek, Jeries Kort, Leland Metheny, et al.
Pageof 12